The Hepcidin Regulator Erythroferrone is a New Member of the Erythropoiesis–Iron–Bone Circuitry
Authors:
Preprint
Abstract
Erythroblast erythroferrone (ERFE) secretion inhibits hepcidin expression by sequestering several bone morphogenetic protein (BMP) family members to increase iron availability for erythropoiesis. We report that ERFE expression in osteoblasts is higher compared with erythroblasts, is independent of erythropoietin, and functional in suppressing hepatocyte hepcidin expression. Erfe -/- mice display low–bone–mass arising from increased bone resorption despite a concomitant increase in bone formation. Consistently, Erfe -/- osteoblasts exhibit enhanced mineralization, Sost and Rankl expression, and BMP–mediated signaling ex vivo . The ERFE effect on osteoclasts is mediated through increased osteoblastic RANKL and sclerostin expression, increasing osteoclastogenesis in Erfe -/- mice. Importantly, Erfe loss in β–thalassemic ( Hbb th3 /+ ) mice, a disease model with increased ERFE expression, triggers profound osteoclastic bone resorption and bone loss. Together, ERFE exerts an osteoprotective effect by modulating BMP signaling in osteoblasts, decreasing RANKL production to limit osteoclastogenesis, and prevents excessive bone loss during expanded erythropoiesis in β–thalassemia.Keywords
All Related Versions
- Published version: eLife, 10.
This publication has 47 references indexed in Scilit:
- A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strengthProceedings of the National Academy of Sciences, 2012
- Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortBlood, 2012
- Changes in Bone Microarchitecture and Biomechanical Properties in the th3 Thalassemia Mouse are Associated with Decreased Bone Turnover and Occur During the Period of Bone AccrualCalcified Tissue International, 2010
- Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload†Hepatology, 2009
- Bone Morphogenic Protein 2 Activates Protein Kinase D to Regulate Histone Deacetylase 7 Localization and Repression of Runx2Journal of Biological Chemistry, 2009
- BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathwayDevelopment, 2008
- Isolation of osteoprogenitors from murine bone marrow by selection of CD11b negative cellsCytotechnology, 2008
- Iron loading: a risk factor for osteoporosisBioMetals, 2006
- The hematological etiology of osteoporosisMedical Hypotheses, 2006
- Association between Oxidative Stress and Bone Mineral DensityBiochemical and Biophysical Research Communications, 2001